MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Drug Design Development and Therapy
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

97 results · 1 filter active ·
Results by year
20082025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
97 works in the cohort · of 4,299,418page 2 of 2

Labels cover 0 of 97 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 97 of 97 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

fundno affunlabeled
A novel small-molecule inhibitor of HIV-1 entry
Erik de Leeuw, Alonso Heredia, Olga Latinovic, Florent Barbault
2015· article· en· Drug Design Development and Therapy· Medicine
distilled prediction:candidate · noneconsensus · none
10
citations
affunlabeled
<p>Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)</p>
Woo‐Baek Chung, Sang‐Hyun Ihm, Sung‐Won Jang, Sung‐Ho Her, Chul Soo Park, Jong Min Lee +4 more
2020· article· en· Drug Design Development and Therapy· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
10
citations
← previous

How this was built: Screen · Findings · About